Integrated untargeted/targeted metabolomics identifies a putative oxylipin signature in patients with atrial fibrillation and coronary heart disease
This study updates metabolic insights of AF and CHD and provides potential therapeutic targets for preventing or treating AF comorbid CHD.
Authors
- Yi‐Da Tang (ORCID: https://orcid.org/0000-0002-9712-803X)
- Jiaxu Sun (ORCID: https://orcid.org/0000-0003-0672-5953)
- Yingyuan Lu (ORCID: https://orcid.org/0000-0003-2426-9154)
- Haiyi Yu (ORCID: https://orcid.org/0000-0003-0761-5270)
- Guomin Hu
- Yong Jiang (ORCID: https://orcid.org/0000-0001-6047-3342)
- Shuwang Liu
- Yisheng Xu (ORCID: https://orcid.org/0000-0003-1433-3714)
- Xiangrui Zeng (ORCID: https://orcid.org/0000-0002-8589-4474)
- Meng Fang (ORCID: https://orcid.org/0000-0001-8788-5224)
- Lei Li (ORCID: https://orcid.org/0000-0001-5478-5681)
- Wenxin Zhang (ORCID: https://orcid.org/0000-0001-5264-6709)
- Zhiyong Du
- Lingli Wang (ORCID: https://orcid.org/0000-0003-2756-5346)
- Pengfei Tu (ORCID: https://orcid.org/0000-0002-3848-8174)
- Ying Wei (ORCID: https://orcid.org/0000-0002-7627-1945)
- Xiaoyu Guo (ORCID: https://orcid.org/0000-0001-8953-7645)
Institutions
- King University (US)
- Capital Medical University (CN)
- Peking University (CN)
- Waters (China) (CN)
- Beijing Anzhen Hospital (CN)
- Beijing Institute of Water (CN)
- Peking University Third Hospital (CN)
Publication Details
- Journal
- Journal of Translational Internal Medicine
- Published
- 2024-11-01
- DOI
- https://doi.org/10.1515/jtim-2023-0141
- Citations
- 10
- Primary Topic
- Eicosanoids and Hypertension Pharmacology
- Type
- article
- Field-Weighted Citation Impact
- 2.95
Funders
- National Natural Science Foundation of China
- Peking University